GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Medicus Sciences Acquisition Corp (NAS:MSAC) » Definitions » EPS (Diluted)

Medicus Sciences Acquisition (Medicus Sciences Acquisition) EPS (Diluted) : $0.32 (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Medicus Sciences Acquisition EPS (Diluted)?

Medicus Sciences Acquisition's Earnings per Share (Diluted) for the three months ended in Sep. 2022 was $0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was $0.32.

Medicus Sciences Acquisition's EPS (Basic) for the three months ended in Sep. 2022 was $0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2022 was $0.32.

Medicus Sciences Acquisition's EPS without NRI for the three months ended in Sep. 2022 was $0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2022 was $0.32.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Medicus Sciences Acquisition EPS (Diluted) Historical Data

The historical data trend for Medicus Sciences Acquisition's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Sciences Acquisition EPS (Diluted) Chart

Medicus Sciences Acquisition Annual Data
Trend Dec20 Dec21
EPS (Diluted)
- 0.18

Medicus Sciences Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EPS (Diluted) Get a 7-Day Free Trial 0.19 -0.04 0.19 0.14 0.03

Competitive Comparison of Medicus Sciences Acquisition's EPS (Diluted)

For the Shell Companies subindustry, Medicus Sciences Acquisition's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Sciences Acquisition's PE Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medicus Sciences Acquisition's PE Ratio falls into.



Medicus Sciences Acquisition EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Medicus Sciences Acquisition's Diluted EPS for the fiscal year that ended in Dec. 2021 is calculated as

Diluted EPS (A: Dec. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.898-0)/10.327
=0.18

Medicus Sciences Acquisition's Diluted EPS for the quarter that ended in Sep. 2022 is calculated as

Diluted EPS (Q: Sep. 2022 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.383-0)/11.615
=0.03

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Sciences Acquisition  (NAS:MSAC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medicus Sciences Acquisition EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Medicus Sciences Acquisition's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Sciences Acquisition (Medicus Sciences Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
Executives
Eric Cheng officer: Chief Business Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Kenneth Berkovitz director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Christopher Kaster director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Ross Levine director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Judah Drillick officer: Chief Financial Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Jacob Gottlieb director, 10 percent owner, officer: Executive Chairman 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Medicus Sciences Holdings Llc 10 percent owner 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Michael Castor director, 10 percent owner, officer: Chief Executive Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Headlines